UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| 1 |
AGN
Allergan plc
AGN
|
$161M |
| 2 |
Biogen
BIIB
|
$124M |
| 3 |
Wells Fargo
WFC
|
$123M |
| 4 |
Delta Air Lines
DAL
|
$112M |
| 5 |
Danaher
DHR
|
$112M |
Top Sells
| 1 |
Scotiabank
BNS
|
$260M |
| 2 |
Chevron
CVX
|
$221M |
| 3 |
Bank of Montreal
BMO
|
$197M |
| 4 |
Canadian Imperial Bank of Commerce
CM
|
$195M |
| 5 |
Amazon
AMZN
|
$167M |
Sector Composition
| 1 | Technology | 18.95% |
| 2 | Financials | 14.16% |
| 3 | Healthcare | 13.87% |
| 4 | Consumer Discretionary | 11.78% |
| 5 | Industrials | 8.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Comcast
CMCSA
$125B
| $850M | 0.63% |
24,000,848
+1,203,599
| +5% | +$42.6M |
|
27
AT&T
T
$208B
| $837M | 0.62% |
24,923,926
-917,847
| -4% | -$30.8M |
|
28
Walt Disney
DIS
$211B
| $801M | 0.6% |
6,850,980
+722,406
| +12% | +$84.5M |
|
29
Verizon
VZ
$184B
| $773M | 0.57% |
14,474,925
+205,972
| +1% | +$11M |
|
30
NVIDIA
NVDA
$4.15T
| $768M | 0.57% |
2,732,442
+244,803
| +10% | +$68.8M |
|
|
31
Chevron
CVX
$318B
| $748M | 0.56% |
6,113,535
-1,810,926
| -23% | -$221M |
|
32
Boeing
BA
$176B
| $739M | 0.55% |
1,986,771
-17,011
| -0.8% | -$6.33M |
|
33
TJX Companies
TJX
$155B
| $685M | 0.51% |
6,112,330
-861,167
| -12% | -$96.5M |
|
34
Merck
MRK
$210B
| $642M | 0.48% |
9,051,319
-91,245
| -1% | -$6.47M |
|
35
IBM
IBM
$227B
| $638M | 0.47% |
4,219,538
+30,704
| +0.7% | +$4.64M |
|
36
Coca-Cola
KO
$297B
| $625M | 0.46% |
13,527,786
-34,066
| -0.3% | -$1.57M |
|
37
American Express
AXP
$225B
| $622M | 0.46% |
5,844,892
+545,177
| +10% | +$58.1M |
|
38
Abbott
ABT
$230B
| $616M | 0.46% |
8,394,848
-149,338
| -2% | -$11M |
|
39
Oracle
ORCL
$628B
| $578M | 0.43% |
11,203,043
-332,977
| -3% | -$17.2M |
|
40
Union Pacific
UNP
$132B
| $574M | 0.43% |
3,526,327
-95,130
| -3% | -$15.5M |
|
41
Citigroup
C
$175B
| $569M | 0.42% |
7,926,396
-150,977
| -2% | -$10.8M |
|
42
Amgen
AMGN
$153B
| $552M | 0.41% |
2,663,948
-114,054
| -4% | -$23.6M |
|
|
AGN
43
DELISTED
Allergan plc
AGN
| $551M | 0.41% |
2,894,528
+842,647
| +41% | +$161M |
|
44
Elevance Health
ELV
$72.4B
| $546M | 0.41% |
1,991,659
-169,260
| -8% | -$46.4M |
|
45
Accenture
ACN
$158B
| $544M | 0.4% |
3,196,806
+172,463
| +6% | +$29.4M |
|
46
Nike
NKE
$110B
| $542M | 0.4% |
6,402,504
+48,429
| +0.8% | +$4.1M |
|
47
AbbVie
ABBV
$374B
| $529M | 0.39% |
5,595,489
-43,583
| -0.8% | -$4.12M |
|
|
48
Biogen
BIIB
$20.8B
| $513M | 0.38% |
1,452,894
+351,238
| +32% | +$124M |
|
49
Thermo Fisher Scientific
TMO
$183B
| $511M | 0.38% |
2,093,017
+24,301
| +1% | +$5.93M |
|
50
Broadcom
AVGO
$1.42T
| $511M | 0.38% |
2,070,454
+319,537
| +18% | +$78.8M |
|